ELVN logo

Enliven Therapeutics, Inc. (ELVN) Total expenses

Annual total expenses:

$89.02M+$17.44M(+24.36%)
December 31, 2024

Summary

  • As of today (August 22, 2025), ELVN annual total expenses is $89.02 million, with the most recent change of +$17.44 million (+24.36%) on December 31, 2024.
  • During the last 3 years, ELVN annual total expenses has risen by +$64.28 million (+259.84%).
  • ELVN annual total expenses is now at all-time high.

Performance

ELVN Total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVNincome statement metrics

Quarterly total expenses:

$25.34M-$3.21M(-11.24%)
June 30, 2025

Summary

  • As of today (August 22, 2025), ELVN quarterly total expenses is $25.34 million, with the most recent change of -$3.21 million (-11.24%) on June 30, 2025.
  • Over the past year, ELVN quarterly total expenses has increased by +$5.38 million (+26.99%).
  • ELVN quarterly total expenses is now -11.24% below its all-time high of $28.54 million, reached on March 31, 2025.

Performance

ELVN Quarterly total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVNincome statement metrics

Total expenses Formula

Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses

ELVN Total expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+24.4%+27.0%
3 y3 years+259.8%+185.0%
5 y5 years+279.4%+148.3%

ELVN Total expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+6082.8%-11.2%+178.7%
5 y5-yearat high+6082.8%-11.2%+178.7%
alltimeall timeat high+6082.8%-11.2%+178.7%

ELVN Total expenses History

DateAnnualQuarterly
Jun 2025
-
$25.34M(-11.2%)
Mar 2025
-
$28.54M(+23.1%)
Dec 2024
$89.02M(+24.4%)
$23.18M(+0.1%)
Sep 2024
-
$23.16M(+16.1%)
Jun 2024
-
$19.95M(-12.3%)
Mar 2024
-
$22.74M(+17.4%)
Dec 2023
$71.58M(-4910.8%)
$19.37M(-6.7%)
Sep 2023
-
$20.77M(+24.2%)
Jun 2023
-
$16.72M(+13.6%)
Mar 2023
-
$14.72M(-145.7%)
Dec 2022
-$1.49M
-$32.19M(-405.0%)
Sep 2022
-
$10.55M(+18.7%)
Jun 2022
-
$8.89M(+2.5%)
DateAnnualQuarterly
Mar 2022
-
$8.67M(-39.5%)
Dec 2021
$24.74M(-40.2%)
-
Dec 2021
-
$14.32M(+4.9%)
Sep 2021
-
$13.65M(+3.7%)
Jun 2021
-
$13.16M(+28.3%)
Mar 2021
-
$10.26M(-10.9%)
Dec 2020
$41.36M(+76.3%)
$11.52M(-7.3%)
Sep 2020
-
$12.42M(+21.7%)
Jun 2020
-
$10.20M(+41.4%)
Mar 2020
-
$7.21M(+9.0%)
Dec 2019
$23.46M(+107.0%)
-
Sep 2019
-
$6.62M
Dec 2018
$11.34M(>+9900.0%)
-
Dec 2017
$0.00
-

FAQ

  • What is Enliven Therapeutics, Inc. annual total expenses?
  • What is the all time high annual total expenses for Enliven Therapeutics, Inc.?
  • What is Enliven Therapeutics, Inc. annual total expenses year-on-year change?
  • What is Enliven Therapeutics, Inc. quarterly total expenses?
  • What is the all time high quarterly total expenses for Enliven Therapeutics, Inc.?
  • What is Enliven Therapeutics, Inc. quarterly total expenses year-on-year change?

What is Enliven Therapeutics, Inc. annual total expenses?

The current annual total expenses of ELVN is $89.02M

What is the all time high annual total expenses for Enliven Therapeutics, Inc.?

Enliven Therapeutics, Inc. all-time high annual total expenses is $89.02M

What is Enliven Therapeutics, Inc. annual total expenses year-on-year change?

Over the past year, ELVN annual total expenses has changed by +$17.44M (+24.36%)

What is Enliven Therapeutics, Inc. quarterly total expenses?

The current quarterly total expenses of ELVN is $25.34M

What is the all time high quarterly total expenses for Enliven Therapeutics, Inc.?

Enliven Therapeutics, Inc. all-time high quarterly total expenses is $28.54M

What is Enliven Therapeutics, Inc. quarterly total expenses year-on-year change?

Over the past year, ELVN quarterly total expenses has changed by +$5.38M (+26.99%)
On this page